An Experimental Weight-Loss Drug Cut Osteoarthritis Pain in Half for Nearly 7 in 10 Patients. The Biggest Question Remains Unanswered
Two critical phase 3 trials conducted by researchers at Northwestern University found that high doses of a new drug had an unexpected benefit.
Original Source
Read the full article at Inc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.